Cynata Therapeutics Ltd has released a press release.
Cynata Completes Clinical Study Report in GvHD
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis
- NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs
- Cynata Receives $1.3m R&D Tax Incentive Refund
- CYP Receives Notice of Allowance from European Patent Office
- September 2018 Quarterly Report
Later from Cynata Therapeutics
- Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHD
- CYP Receives Notice of Acceptance from Aust Patent Office
- December 2018 Quarterly Report
- Cynata Receives Favourable Advice on Planned CLI Trial
- Cynata Extends FUJIFILM Licence Option in GvHD
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics